Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FMT for intestinal decolonization of multidrug-resistant pathogens
NCT04181112Unknown
- Sponsor
- University of British Columbia
- Start
- Nov 2019
- Primary completion
- Nov 2022
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
Randomised trial of allogeneic fecal microbiota in Microbial Colonization (MC) (3 arms), sponsored by University of British Columbia. Primary endpoint: Elimination of the target multi-drug resistant organism at 30 days. Status: unknown.
02
Drugs
allogeneic fecal microbiota
03
Conditions
Microbial Colonization (MC)
Beyond the preview
Go deeper on NCT04181112.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04181112.